If certain key, evidence-based principles are followed, remission is now an achievable goal in asthma treatment. First, it is recommended to routinely supplement spirometry with a blood test to measure eosinophil counts, as this has proven to be an extremely important biomarker. Second, bronchodilator therapy should be combined with anti-inflammatory therapy; highly effective biologics are now available for severe asthma. Third, long-term asthma control is essential, involving the monitoring of progression parameters such as eosinophil count and FeNO and, if necessary, adjustment of therapy.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- Shaping the Future with LLM & Co.
AI in Everyday Clinical Practice: Friend or Foe?
- Ulcerative colitis: current evidence on anti-inflammatory therapies
Remission induction and maintenance with biologics and JAK-i
- Bronchiectasis
New strategies against neutrophilic inflammation
- IBD in childhood
Pneumococcal vaccination without negative consequences
- Seborrheic Dermatitis in Adults and Adolescents
Current State of Knowledge and New Therapeutic Approaches
- Plastic surgery and reconstructive microsurgery for DFS
Functional limb preservation between infection control, vascular medicine and resurfacing
- Orthobiologics for knee osteoarthritis
PRP and hyaluronic acid injections as building blocks in a multimodal concept
- Soft tissue sarcomas of the lower extremity